Alzheimer's disease (AD) is a neurodegenerative disease often accompanied with disruption of sleep-wake cycle. The sleep-wake cycle is controlled by mechanisms involving internal timekeeping (circadian) regulation. The aim of our present pilot study was to assess the circadian system in patients with mild form of AD in their home environment. In the study, 13 elderly AD patients and 13 age-matched healthy control subjects (the patient's spouses) were enrolled. Sleep was recorded for 21 days by sleep diaries in all participants and checked by actigraphy in 4 of the AD patient/control couples. The samples of saliva and buccal mucosa were collected every 4 hours during the same 24 h-interval to detect melatonin and clock gene (PER1 and BMAL1) mRNA levels, respectively. The AD patients exhibited significantly longer inactivity interval during the 24 h and significantly higher number of daytime naps than controls. Daily profiles of melatonin levels exhibited circadian rhythms in both groups. Compared with controls, decline in amplitude of the melatonin rhythm in AD patients was not significant, however, in AD patients more melatonin profiles were dampened or had atypical waveforms. The clock genes PER1 and BMAL1 were expressed rhythmically with high amplitudes in both groups and no significant differences in phases between both groups were detected. Our results suggest moderate differences in functional state of the circadian system in patients with mild form of AD compared with healthy controls which are present in conditions of their home dwelling.

Charles University Prague 3rd Faculty of Medicine Department of Neurology Prague Czech Republic

Department of Neurohumoral Regulations Institute of Physiology the Czech Academy of Sciences Prague Czech Republic

National Institute of Mental Health Klecany Czech Republic

Zobrazit více v PubMed

Vandenberghe R, Tournoy J. Cognitive aging and Alzheimer's disease. Postgrad Med J. 2005;81(956):343–52. . PubMed PMC

Wu YH, Swaab DF. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Med. 2007;8(6):623–36. . PubMed

Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72:517–49. 10.1146/annurev-physiol-021909-135821 PubMed DOI

Morin LP. Neuroanatomy of the extended circadian rhythm system. Exp Neurol. 2012;243:4–20. 10.1016/j.expneurol.2012.06.026 PubMed DOI PMC

Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4(8):649–61. . PubMed

Kalsbeek A, Yi CX, Cailotto C, la Fleur SE, Fliers E, Buijs RM. Mammalian clock output mechanisms. Essays Biochem. 2011;49(1):137–51. 10.1042/BSE0480137 PubMed DOI

Partch CL, Green CB, Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol. 2014;24(2):90–9. 10.1016/j.tcb.2013.07.002 PubMed DOI PMC

Blazer DG, Hays JC, Foley DJ. Sleep complaints in older adults: a racial comparison. J Gerontol A Biol Sci Med Sci. 1995;50(5):M280–4. . PubMed

Van Someren EJ. Circadian and sleep disturbances in the elderly. Exp Gerontol. 2000;35(9–10):1229–37. . PubMed

Myers BL, Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci Biobehav Rev. 1995;19(4):553–71. . PubMed

Van Someren EJ. Circadian rhythms and sleep in human aging. Chronobiol Int. 2000;17(3):233–43. . PubMed

Hofman MA, Swaab DF. Living by the clock: the circadian pacemaker in older people. Ageing Res Rev. 2006;5(1):33–51. . PubMed

Duffy JF, Czeisler CA. Age-related change in the relationship between circadian period, circadian phase, and diurnal preference in humans. Neurosci Lett. 2002;318(3):117–20. Epub 2002/01/23. doi: S0304394001024272 [pii]. . PubMed

Duffy JF, Zeitzer JM, Rimmer DW, Klerman EB, Dijk DJ, Czeisler CA. Peak of circadian melatonin rhythm occurs later within the sleep of older subjects. Am J Physiol Endocrinol Metab. 2002;282(2):E297–303. Epub 2002/01/15. 10.1152/ajpendo.00268.2001 . PubMed DOI

Vitiello MV, Prinz PN, Williams DE, Frommlet MS, Ries RK. Sleep disturbances in patients with mild-stage Alzheimer's disease. J Gerontol. 1990;45(4):M131–8. . PubMed

McCurry SM, Logsdon RG, Teri L, Gibbons LE, Kukull WA, Bowen JD, et al. Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients. J Geriatr Psychiatry Neurol. 1999;12(2):53–9. . PubMed

Bonanni E, Maestri M, Tognoni G, Fabbrini M, Nucciarone B, Manca ML, et al. Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with cognitive impairment. J Sleep Res. 2005;14(3):311–7. . PubMed

Arendt J. Melatonin and human rhythms. Chronobiol Int. 2006;23(1–2):21–37. . PubMed

Skene DJ, Swaab DF. Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp Gerontol. 2003;38(1–2):199–206. . PubMed

Zeitzer JM, Daniels JE, Duffy JF, Klerman EB, Shanahan TL, Dijk DJ, et al. Do plasma melatonin concentrations decline with age? Am J Med. 1999;107(5):432–6. Epub 1999/11/24. doi: S0002-9343(99)00266-1 [pii]. . PubMed

Zeitzer JM, Duffy JF, Lockley SW, Dijk DJ, Czeisler CA. Plasma melatonin rhythms in young and older humans during sleep, sleep deprivation, and wake. Sleep. 2007;30(11):1437–43. Epub 2007/11/29. PubMed PMC

Zhou JN, Liu RY, Kamphorst W, Hofman MA, Swaab DF. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res. 2003;35(2):125–30. . PubMed

Liu RY, Zhou JN, van Heerikhuize J, Hofman MA, Swaab DF. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab. 1999;84(1):323–7. . PubMed

Harper DG, Volicer L, Stopa EG, McKee AC, Nitta M, Satlin A. Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am J Geriatr Psychiatry. 2005;13(5):359–68. . PubMed

Swaab DF, Fliers E, Partiman TS. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 1985;342(1):37–44. . PubMed

Hofman MA, Swaab DF. Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res. 1994;651(1–2):134–42. . PubMed

Hofman MA, Swaab DF. Influence of aging on the seasonal rhythm of the vasopressin-expressing neurons in the human suprachiasmatic nucleus. Neurobiol Aging. 1995;16(6):965–71. . PubMed

Liu RY, Zhou JN, Hoogendijk WJ, van Heerikhuize J, Kamphorst W, Unmehopa UA, et al. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J Neuropathol Exp Neurol. 2000;59(4):314–22. . PubMed

Stopa EG, Volicer L, Kuo-Leblanc V, Harper D, Lathi D, Tate B, et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol. 1999;58(1):29–39. . PubMed

Harper DG, Stopa EG, Kuo-Leblanc V, McKee AC, Asayama K, Volicer L, et al. Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. Brain. 2008;131(Pt 6):1609–17. 10.1093/brain/awn049 PubMed DOI PMC

Zhou JN, Hofman MA, Swaab DF. VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging. 1995;16(4):571–6. . PubMed

Baloyannis SJ, Mavroudis I, Mitilineos D, Baloyannis IS, Costa VG. The Hypothalamus in Alzheimer's Disease: A Golgi and Electron Microscope Study. Am J Alzheimers Dis Other Demen. 2014. . PubMed PMC

Wu YH, Fischer DF, Kalsbeek A, Garidou-Boof ML, van der Vliet J, van Heijningen C, et al. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock". Faseb J. 2006;20(11):1874–6. . PubMed

Amir S, Lamont EW, Robinson B, Stewart J. A circadian rhythm in the expression of PERIOD2 protein reveals a novel SCN-controlled oscillator in the oval nucleus of the bed nucleus of the stria terminalis. J Neurosci. 2004;24(4):781–90. . PubMed PMC

Cermakian N, Lamont EW, Boudreau P, Boivin DB. Circadian clock gene expression in brain regions of Alzheimer 's disease patients and control subjects. J Biol Rhythms. 2011;26(2):160–70. 10.1177/0748730410395732 PubMed DOI

Coogan AN, Schutova B, Husung S, Furczyk K, Baune BT, Kropp P, et al. The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities. Biol Psychiatry. 2013;74(5):333–9. 10.1016/j.biopsych.2012.11.021 PubMed DOI

Bedrosian TA, Nelson RJ. Pro: Alzheimer's disease and circadian dysfunction: chicken or egg? Alzheimers Res Ther. 2012;4(4):25 10.1186/alzrt128 PubMed DOI PMC

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263–9. 10.1016/j.jalz.2011.03.005 PubMed DOI PMC

Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98. . PubMed

Novakova M, Paclt I, Ptacek R, Kuzelova H, Hajek I, Sumova A. Salivary melatonin rhythm as a marker of the circadian system in healthy children and those with attention-deficit/hyperactivity disorder. Chronobiol Int. 2011;28(7):630–7. 10.3109/07420528.2011.596983 PubMed DOI

Novakova M, Nevsimalova S, Prihodova I, Sladek M, Sumova A. Alteration of the circadian clock in children with Smith-Magenis syndrome. J Clin Endocrinol Metab. 2012;97(2):E312–8. 10.1210/jc.2011-2750 PubMed DOI

Novakova M, Sladek M, Sumova A. Human chronotype is determined in bodily cells under real-life conditions. Chronobiol Int. 2013;30(4):607–17. 10.3109/07420528.2012.754455 PubMed DOI

Novakova M, Sumova A. New methods to assess circadian clocks in humans. Indian J Exp Biol. 2014;52(5):404–12. . PubMed

Satlin A, Teicher MH, Lieberman HR, Baldessarini RJ, Volicer L, Rheaume Y. Circadian locomotor activity rhythms in Alzheimer's disease. Neuropsychopharmacology. 1991;5(2):115–26. . PubMed

van Someren EJ, Hagebeuk EE, Lijzenga C, Scheltens P, de Rooij SE, Jonker C, et al. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry. 1996;40(4):259–70. . PubMed

Redline S, Kirchner HL, Quan SF, Gottlieb DJ, Kapur V, Newman A. The effects of age, sex, ethnicity, and sleep-disordered breathing on sleep architecture. Arch Intern Med. 2004;164(4):406–18. . PubMed

Lee JH, Bliwise DL, Ansari FP, Goldstein FC, Cellar JS, Lah JJ, et al. Daytime sleepiness and functional impairment in Alzheimer disease. Am J Geriatr Psychiatry. 2007;15(7):620–6. . PubMed

Hatfield CF, Herbert J, van Someren EJ, Hodges JR, Hastings MH. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain. 2004;127(Pt 5):1061–74. . PubMed

Zhou JN, Liu RY, van Heerikhuize J, Hofman MA, Swaab DF. Alterations in the circadian rhythm of salivary melatonin begin during middle-age. J Pineal Res. 2003;34(1):11–6. . PubMed

Pfeffer RI, Kurosaki TT, Harrah CH Jr., Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323–9. Epub 1982/05/01. . PubMed

Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967–72. Epub 1992/10/01. PubMed PMC

Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–6. Epub 1987/08/01. 10.2214/ajr.149.2.351 . PubMed DOI

Circadian dysfunction and cardio-metabolic disorders in humans

The McGill Transgenic Rat Model of Alzheimer's Disease Displays Cognitive and Motor Impairments, Changes in Anxiety and Social Behavior, and Altered Circadian Activity